News

Read the full press release from RPRD Diagnostics here.  RPRD (Right Patient Right Drug) Diagnostics and St. Jude Children’s Research Hospital today announced their recent publication, “Challenges in clinical implementation of CYP2D6 genotyping: choice of variants to test affects phenotype determination,” in Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics. In this article […]

Read the full press release here. General Capital Group, a real estate development company specializing in life sciences development and other complex build-to-suits, recently celebrated Illumina’s new space – a build-to-suit R&D, production lab and office facility adjacent to the University of Wisconsin’s University Research Park in Madison, Wisconsin. A select group of community members, […]

Read the full article from the University of Wisconsin – Madison here. The University of Wisconsin–Madison has been ranked 25th worldwide by the Center for World University Rankings, up from 27th last year. The university placed 19th nationally (21st last year), quality of education, 28th(65th last year); alumni employment, 80th (79th last year); quality of faculty, 35th (32nd last year). The Center for World […]

Read the full story from PR Newswire here. EQT to partner with founder and CEO Michael Chambers, as well as TA Associates, to support Aldevron on its future growth journey EQT will support Aldevron through investments in additional production capacity, R&D, and growth initiatives and by leveraging EQT’s strong healthcare expertise, global presence, and network […]

Read the full press release from Exact Sciences here. Joins two of the strongest brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growthForms best-in-class commercial, research, development and clinical organization, with enhanced scale and scope in cancer diagnosticsGlobal infrastructure accelerates the ability to provide new innovative cancer diagnostics to […]

Read the full press release here. Dr. Kim McDowell has been appointed to oversee the regulatory affairs of the Program for Advanced Cell Therapy (PACT). Her main duties will include crafting and managing investigational new drug (IND) and investigational device exemption (IDE) applications for PACT-sponsored clinical trials and regulatory compliance. “Dr. McDowell brings with her the […]